Skip to Content

Drug Interactions between Herzuma and influenza virus vaccine, live, trivalent

This report displays the potential drug interactions for the following 2 drugs:

  • Herzuma (trastuzumab)
  • influenza virus vaccine, live, trivalent

Edit list (add/remove drugs)

Interactions between your drugs


trastuzumab influenza virus vaccine, live

Applies to: Herzuma (trastuzumab) and influenza virus vaccine, live, trivalent

If you are currently being treated or have recently been treated with trastuzumab, you should let your doctor know before receiving influenza virus vaccine, live. Depending on the dose and length of time you have been on trastuzumab, you may be at risk for developing an infection from the vaccine or have a reduced response to the vaccine. In some situations, your doctor may want to delay vaccination to give your body time to recover from the effects of trastuzumab therapy. Conversely, if you have recently been vaccinated with influenza virus vaccine, live, your doctor may choose to postpone treatment with trastuzumab for a few weeks. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Drug and food interactions

No interactions were found. This does not necessarily mean no interactions exist. Always consult your healthcare provider.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.